Sieva Kozinsky discusses the unit economics and business model of a clinical trial site network he previously founded and sold.
0:00 / 0:12exact quote · 12.2s
720p mp4 · rendered on demand · StarZero watermark
“So it was a marketplace model, and our customers were like Pfizer and Novartis and Inovoderm, and they would pay us 10 to 20,000 dollars per patient to recruit a patient. We would split that with the doctor.”
quote is from the automated transcript, cleaned for reading:
filler sounds and stutters are removed, nothing is rephrased. names can be misheard
(the analysis reads context, assessments check outside sources). how →
More from Sieva Kozinsky
PredictionNot checkable as stated
Kozinsky: More VC 'fallen angels' will seek soft landings within two years
“There's probably going to be more opportunities like up council and our other businesses. That's the VC fallen angels, the businesses that have raised a lot of capital, but maybe haven't grown into, haven't fully grown into the scale that they should be at. So…”
Sieva KozinskyJul 19, 2022▶ 34:31Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Disclosure
Kozinsky: Enduring Ventures targets 3x-5x cash flow multiples for acquisitions
“We really like to buy at valuations that are three to five times cashflow. So if a business does a million dollars of cashflow per year, We really want, don't want to pay more than three to five million dollars to acquire it, and you really can't get that in m…”
Sieva KozinskyJul 19, 2022▶ 11:58Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Disclosure
Enduring Ventures Targets Unprofitable Venture-Backed Tech Startups With Strong Revenue
“We've actually redirected our focus in tech to just focus on businesses like UpCouncil that have good revenue that don't quite have the profits to support it and that we can turn around and create a cashflow engine from them because in those situations we can …”
Sieva KozinskyJul 19, 2022▶ 12:07Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Insight
Kozinsky: Founders should start exit planning 3 to 5 years early
“I actually recommend, at the very least, thinking about your sale process three years before you plan to do it, and ideally even four or five years if you're not in a rush, right, because you can really optimize your business for the sale”
Sieva KozinskyJul 19, 2022▶ 21:01Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Insight
Kozinsky: Founders selling to PE must demonstrate profitability or clear profit levers
“If you're a year out or you're two years out and you've had zero profit this whole time, which many businesses do or negative profit, consider showing profit or considering structuring your business so that you can make it very clear to the buyer that these tw…”
Sieva KozinskyJul 19, 2022▶ 27:57Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Disclosure
Kozinsky: Enduring Ventures Buys Cash-Flowing Businesses to Hold Forever
“So enduring is a long-term holding company. What we do is we buy cash flowing businesses at reasonable prices and we pair them with great operators and we run them and we hold them as a portfolio forever. That's our plan.”
Sieva KozinskyJul 19, 2022▶ 1:06Startup Acquisition Stories with Sieva Kozinsky - Founder of Enduring Ventures
Made with StarZero
Turn any episode into a week of clips.
This entire site, over 100 episodes transcribed, diarized, checked and made playable,
runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the
moments worth sharing, cuts them, captions them, and reframes them for every feed.
We use essential cookies to make the site work. With your permission we
also use analytics cookies (Google Analytics and Mixpanel) to understand
usage and improve StarZero. See our Cookie Policy.